Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Novel fused pyrimidine and isoquinoline derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2016105532A1, WO2016105534A1 and WO2016105564A1, Expert Opinion on Therapeutic Patents, March 2017, Taylor & Francis,
DOI: 10.1080/13543776.2017.1303046.
You can read the full text:

Read

Contributors

The following have contributed to this page